[go: up one dir, main page]

PT1474067E - Vacinação numa dose com mycoplasma hyopneumoniae - Google Patents

Vacinação numa dose com mycoplasma hyopneumoniae Download PDF

Info

Publication number
PT1474067E
PT1474067E PT02735755T PT02735755T PT1474067E PT 1474067 E PT1474067 E PT 1474067E PT 02735755 T PT02735755 T PT 02735755T PT 02735755 T PT02735755 T PT 02735755T PT 1474067 E PT1474067 E PT 1474067E
Authority
PT
Portugal
Prior art keywords
vaccination
dose
mycoplasma hyopneumoniae
hyopneumoniae
mycoplasma
Prior art date
Application number
PT02735755T
Other languages
English (en)
Inventor
Robin Lee Keich
Lisa Grace Sabbadini
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23168589&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1474067(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PT1474067E publication Critical patent/PT1474067E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0241Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/87Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT02735755T 2001-07-02 2002-06-07 Vacinação numa dose com mycoplasma hyopneumoniae PT1474067E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30263601P 2001-07-02 2001-07-02

Publications (1)

Publication Number Publication Date
PT1474067E true PT1474067E (pt) 2008-11-14

Family

ID=23168589

Family Applications (3)

Application Number Title Priority Date Filing Date
PT81677619T PT2027873E (pt) 2001-07-02 2002-06-07 Vacinação de dose única com mycoplasma hyopneumoniae
PT14182639T PT2842569T (pt) 2001-07-02 2002-06-07 Vacinação de dose única com mycoplasma hyopneumoniae
PT02735755T PT1474067E (pt) 2001-07-02 2002-06-07 Vacinação numa dose com mycoplasma hyopneumoniae

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PT81677619T PT2027873E (pt) 2001-07-02 2002-06-07 Vacinação de dose única com mycoplasma hyopneumoniae
PT14182639T PT2842569T (pt) 2001-07-02 2002-06-07 Vacinação de dose única com mycoplasma hyopneumoniae

Country Status (42)

Country Link
US (3) US6846477B2 (pt)
EP (3) EP2027873B8 (pt)
JP (1) JP2005515162A (pt)
KR (1) KR20040030785A (pt)
CN (3) CN102872456B (pt)
AP (1) AP2003002937A0 (pt)
AR (1) AR034678A1 (pt)
AT (1) ATE412426T2 (pt)
AU (1) AU2002309109B2 (pt)
BG (1) BG66481B1 (pt)
BR (1) BR0210804A (pt)
CA (1) CA2451626C (pt)
CY (1) CY1108749T1 (pt)
CZ (1) CZ305781B6 (pt)
DE (1) DE60229666D1 (pt)
DK (3) DK2842569T3 (pt)
DO (1) DOP2002000431A (pt)
EA (1) EA009901B1 (pt)
ES (3) ES2312580T5 (pt)
GT (1) GT200200138A (pt)
HK (1) HK1207584A1 (pt)
HR (1) HRP20031079A2 (pt)
HU (1) HU230246B1 (pt)
IL (1) IL159349A0 (pt)
IS (1) IS7076A (pt)
MA (1) MA27047A1 (pt)
MX (1) MXPA03011599A (pt)
NO (1) NO342654B1 (pt)
NZ (1) NZ530106A (pt)
OA (1) OA12638A (pt)
PA (1) PA8549701A1 (pt)
PE (1) PE20030285A1 (pt)
PL (1) PL209773B1 (pt)
PT (3) PT2027873E (pt)
SK (1) SK288010B6 (pt)
TN (1) TNSN03155A1 (pt)
TW (1) TWI329514B (pt)
UA (1) UA78707C2 (pt)
UY (1) UY27366A1 (pt)
WO (1) WO2003003941A2 (pt)
YU (1) YU102203A (pt)
ZA (1) ZA200309698B (pt)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY129765A (en) * 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
WO2006056841A1 (en) * 2004-11-24 2006-06-01 Pharmacia & Upjohn Company Llc Multiple-strain mycoplasma hyopneumoniae vaccines
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
RU2488407C2 (ru) 2005-12-29 2013-07-27 Берингер Ингельхайм Ветмедика, Инк. Поливалентные иммуногенные композиции pcv2 и способы получения таких композиций
DK2371383T3 (en) 2005-12-29 2015-11-30 Boehringer Ingelheim Vetmed Use of a PCV2 immunogenic composition for reduction of clinical symptoms in pigs
AU2007222016A1 (en) * 2006-03-03 2007-09-13 Merial Limited Mycoplasma hyopneumoniae vaccine
EP2099927A4 (en) * 2006-11-22 2010-05-05 Boehringer Ingelheim Vetmed Methods of reducing porcine circovirus-associated disease outbreaks
US20100129397A1 (en) 2006-12-11 2010-05-27 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
DK2481420T3 (da) 2006-12-15 2019-05-06 Boehringer Ingelheim Animal Health Usa Inc Enkeltdosis-anti-PCV2-svinevaccine
EP1941903A1 (en) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
AU2008324780A1 (en) 2007-11-06 2009-05-14 Pah W Llc Mycoplasma hyopneumoniae avirulent -adjuvanted live vaccine
AU2008347235A1 (en) * 2007-12-31 2009-07-16 Boehringer Ingelheim Vetmedica, Inc. PCV2 ORF2 virus like particle with foreign amino acid insertion
CN101236206B (zh) * 2008-01-17 2014-10-15 中国兽医药品监察所 一种猪肺炎支原体重组抗原elisa检测试剂盒
EP2242511A4 (en) * 2008-01-23 2012-10-24 Boehringer Ingelheim Vetmed IMMUNOGENIC COMPOSITIONS OF MYCOPLASMA HYOPNEUMONIAE PCV2, AND METHODS FOR PRODUCING SUCH COMPOSITIONS
US8444989B1 (en) * 2008-04-18 2013-05-21 Boehringer Ingelheim Vetmedica Gmbh One dose vaccination against mycoplasma infections of pigs
NZ621834A (en) 2008-06-27 2015-10-30 Zoetis Services Llc Novel adjuvant compositions
AU2010255182B2 (en) 2009-06-04 2016-03-10 Japan Institute For Health Security Vaccine for mycoplasma infection
TWI627281B (zh) 2009-09-02 2018-06-21 百靈佳殷格翰家畜藥品公司 降低pcv-2組合物殺病毒活性之方法及具有改良免疫原性之pcv-2組合物
EP3187585A1 (en) 2010-03-25 2017-07-05 Oregon Health&Science University Cmv glycoproteins and recombinant vectors
WO2011141443A1 (en) 2010-05-11 2011-11-17 Intervet International B.V. Vaccine against mycoplasma hyopneumoniae, suitable for administration in the presence of maternally derived antibodies
PL2598165T3 (pl) * 2010-07-26 2018-02-28 Qu Biologics Inc. Immunogenne kompozycje przeciwzapalne
US8546149B2 (en) 2010-08-27 2013-10-01 Intervet Inc. Potency test for vaccine formulations
BR112013004594B1 (pt) * 2010-08-27 2020-07-28 Intervet International B. V. método para a determinação de um conteúdo de antígeno
ES2667425T3 (es) 2011-06-10 2018-05-10 Oregon Health & Science University Glucoproteínas y vectores recombinantes de CMV
CA2866199A1 (en) * 2012-03-07 2013-09-12 Ceva Sante Animale Novel veterinary vaccine
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
EP3730148A3 (en) 2012-12-28 2021-03-24 Boehringer Ingelheim Vetmedica GmbH Immunogenic composition comprising mycoplasma antigens
MX361273B (es) 2012-12-28 2018-12-03 Boehringer Ingelheim Vetmedica Gmbh Metodo para obtener una vacuna de mycoplasma.
KR101758778B1 (ko) * 2013-02-05 2017-07-18 애그리컬쳐럴 테크놀로지 리서치 인스티튜트 항-마이코플라즈마 에스피피. 아단위 백신
CN104338125A (zh) * 2013-07-29 2015-02-11 普莱柯生物工程股份有限公司 一种猪肺炎支原体抗原在预防和治疗猪呼吸道疾病综合征方面的应用
NZ757210A (en) 2013-09-19 2022-12-23 Zoetis Services Llc Oil-based adjuvants
CN105658660A (zh) 2013-10-02 2016-06-08 勃林格殷格翰动物保健公司 Pcv2 orf2蛋白变体和由其组成的病毒样颗粒
CN105792841B (zh) 2013-11-21 2019-07-26 财团法人农业科技研究院 防治霉浆菌感染的组合物
CN105012948B (zh) * 2014-04-18 2019-07-30 普莱柯生物工程股份有限公司 一种疫苗组合物及其应用
CN104248753B (zh) * 2014-05-15 2017-07-28 普莱柯生物工程股份有限公司 一种疫苗组合物及其应用
BR102014014727B1 (pt) * 2014-06-16 2018-04-03 Ouro Fino Saúde Animal Ltda COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae, GENE SINTÉTICO CODIFICANTE DO COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae, COMPOSIÇÃO ANTIGÊNICA, PROCESSO DE OBTENÇÃO DE UM COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae
US9814769B2 (en) 2014-09-30 2017-11-14 Qatar University Vaccines against pathogenic Escherichia coli and methods of using the same
AR103427A1 (es) 2015-01-16 2017-05-10 Zoetis Services Llc Vacuna contra la fiebre aftosa
KR20160099223A (ko) * 2015-02-12 2016-08-22 강원대학교산학협력단 마이코플라스마 하이오뉴모니애 박테린 백신 및 이의 제조방법
EP3498847A4 (en) * 2016-08-12 2020-03-04 Innovac VACCINE COMPOSITION FOR PREVENTING SWINE MYCOPLASM INFECTION COMPRISING A RECOMBINANT PROTEIN
RU2668799C1 (ru) * 2017-09-08 2018-10-02 Эгрикалчурал Текнолоджи Рисерч Инститьют Субъединичная вакцина против mycoplasma spp.
CN108101969A (zh) * 2017-11-13 2018-06-01 南京大爻网络科技有限公司 一种与猪支原体肺炎相关的抗原及其应用
RU2695679C1 (ru) * 2018-09-11 2019-07-25 Эгрикалчурал Текнолоджи Рисерч Инститьют Субъединичная вакцина против mycoplasma spp.
RU2759427C2 (ru) * 2019-07-08 2021-11-12 Эгрикалчурал Текнолоджи Рисерч Инститьют Субъединичная вакцина против mycoplasma spp
CN117305192A (zh) * 2023-12-01 2023-12-29 北京瑞阳瑞泰生物科技有限公司 一种猪肺炎支原体rt02株、疫苗组合物及其应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252328A (en) * 1987-03-26 1993-10-12 Martin Marietta Energy Systems, Inc. Mycoplasma hyopneumoniae antigen and uses therefor
EP0283840A3 (en) * 1987-03-26 1989-08-09 Ml Technology Ventures, L.P. Mycoplasma hyopneumoniae antigen and uses therefor
ES2058237T3 (es) 1987-09-18 1994-11-01 Akzo Nv Metodo para la preparacion de una vacuna para combatir la infeccion mycoplasmica en aves de corral.
JPH05506984A (ja) 1990-04-02 1993-10-14 サイナーゲン,インコーポレーテッド 動物におけるマイコプラズマ感染に対する診断と治療に有用なポリペプチド
WO1994007531A1 (en) * 1992-09-28 1994-04-14 Pfizer Inc Method of enhancing cell mediated immune responses
JP3187419B2 (ja) * 1990-05-29 2001-07-11 アメリカン・サイアナミド・カンパニー ブタ肺炎ワクチンおよびその製造方法
US6113916A (en) * 1990-05-29 2000-09-05 American Cyanamid Company Method of enhancing cell mediated immune responses
US5565205A (en) 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
EP0475185A1 (en) 1990-08-27 1992-03-18 Nippon Flour Mills Co., Ltd. DNA's encoding surface antigen of mycoplasma hyopneumoniae, DNA fragments for primer, recombinant antigenic peptides and diagnostic method of mycoplasmal pneumoniae of swine using same
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US5530874A (en) 1993-02-02 1996-06-25 3Com Corporation Network adapter with an indication signal mask and an interrupt signal mask
WO1995009870A1 (en) 1993-10-07 1995-04-13 Iowa State University Research Foundation, Inc. Characterization of mycoplasma hyopneumoniae adhesins
CN1268393C (zh) 1994-05-10 2006-08-09 惠氏公司 经改良修饰的brsv或疫苗
US5788962A (en) 1995-01-17 1998-08-04 The Curators Of The University Of Missouri DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures
AUPN178995A0 (en) * 1995-03-16 1995-04-13 University Of Melbourne, The Antigen composition
AU715555B2 (en) 1996-09-30 2000-02-03 University Of Arkansas, The Method of producing active immunity with vaccine conjugate
EP0846468B1 (en) 1996-12-05 2004-06-09 Akzo Nobel N.V. Non-virulent mycoplasma synoviae and vaccine thereof
BR9815321A (pt) 1997-11-26 2002-01-02 Univ Iowa State Res Found Inc Vacina de mycoplasma hyopneumoniae recombinante
AU6128900A (en) * 1999-09-29 2001-04-05 Pfizer Products Inc. Nucleic acids and proteins of the mycoplasma hyopneumoniae mph3 gene and uses thereof
US6585981B1 (en) * 2000-07-27 2003-07-01 Regents Of The University Of Minnesota Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs

Also Published As

Publication number Publication date
EP1474067A2 (en) 2004-11-10
EP1474067B1 (en) 2008-10-29
ES2550458T3 (es) 2015-11-10
CN101524532A (zh) 2009-09-09
OA12638A (en) 2006-06-15
BG108546A (bg) 2005-02-28
EP2842569B1 (en) 2019-04-10
US20030109473A1 (en) 2003-06-12
IS7076A (is) 2003-12-15
EA009901B1 (ru) 2008-04-28
ATE412426T2 (de) 2008-11-15
CY1108749T1 (el) 2014-04-09
NZ530106A (en) 2007-06-29
DK1474067T4 (en) 2017-10-16
BG66481B1 (bg) 2015-02-27
CA2451626A1 (en) 2003-01-16
PE20030285A1 (es) 2003-03-27
AR034678A1 (es) 2004-03-03
PL209773B1 (pl) 2011-10-31
GT200200138A (es) 2003-05-15
EP1474067A4 (en) 2005-08-10
PA8549701A1 (es) 2003-01-24
SK288010B6 (sk) 2012-10-02
ES2312580T3 (es) 2009-03-01
HK1134900A1 (zh) 2010-05-20
WO2003003941A2 (en) 2003-01-16
AP2003002937A0 (en) 2003-12-31
US20050013823A1 (en) 2005-01-20
NO20035762L (no) 2004-02-02
ES2729579T3 (es) 2019-11-04
CN1551781A (zh) 2004-12-01
EP2027873B8 (en) 2015-11-11
PL373367A1 (en) 2005-08-22
HK1207584A1 (en) 2016-02-05
EA200301323A1 (ru) 2005-06-30
NO342654B1 (no) 2018-06-25
MXPA03011599A (es) 2005-03-07
USRE44399E1 (en) 2013-07-30
EP1474067B2 (en) 2017-08-16
UY27366A1 (es) 2003-04-30
YU102203A (sh) 2006-05-25
KR20040030785A (ko) 2004-04-09
CZ20033466A3 (cs) 2005-06-15
DK1474067T3 (da) 2008-12-08
HK1068250A1 (en) 2005-04-29
CN101524532B (zh) 2014-03-19
CZ305781B6 (cs) 2016-03-16
PT2027873E (pt) 2015-11-03
PT2842569T (pt) 2019-06-17
TWI329514B (en) 2010-09-01
DK2027873T3 (en) 2015-11-09
BR0210804A (pt) 2005-05-03
CN102872456B (zh) 2016-01-20
DK2842569T3 (da) 2019-05-20
DOP2002000431A (es) 2003-01-15
WO2003003941A3 (en) 2004-07-29
US6846477B2 (en) 2005-01-25
HU230246B1 (hu) 2015-11-30
CN102872456A (zh) 2013-01-16
JP2005515162A (ja) 2005-05-26
ES2312580T5 (es) 2017-12-11
EP2027873B1 (en) 2015-09-09
CN1551781B (zh) 2013-01-02
EP2027873A1 (en) 2009-02-25
HRP20031079A2 (en) 2005-10-31
IL159349A0 (en) 2004-06-01
DE60229666D1 (de) 2008-12-11
EP2842569A1 (en) 2015-03-04
ZA200309698B (en) 2014-04-30
HUP0400434A2 (en) 2007-08-28
SK15792003A3 (sk) 2005-09-08
TNSN03155A1 (fr) 2005-12-23
AU2002309109B2 (en) 2007-12-13
HK1180224A1 (zh) 2013-10-18
MA27047A1 (fr) 2004-12-20
UA78707C2 (en) 2007-04-25
CA2451626C (en) 2011-05-31

Similar Documents

Publication Publication Date Title
PT1474067E (pt) Vacinação numa dose com mycoplasma hyopneumoniae
DE60127994D1 (de) VERBESSERTE i MYCOPLASMA HYOPNEUMONIAE /i BACTERIN VAKZINE
DE10196905T1 (de) Übungsgerät
ATE253327T1 (de) Röntgenstrahlendurchlässiges führungselement
FI4823U1 (fi) Muunnetulla tavalla vapauttava lääkeformulaatio
DE60125887D1 (de) Übungsgerät
SI1546357T1 (sl) Imunogeni polipeptidi mycoplasma hyopneumoniae
ATE282603T1 (de) Bicyclyl oder heterobicyclyl methanesulfonylamino-substituierte n-hydroxyformamide
DE60209391D1 (de) Blattzufuhrvorrichtung mit Gegenkräften
UA9199S (uk) Упаковка для лікарського засобу «фонг тхап тху»
UA8379S (uk) Упаковка для лікарського засобу «фонг тхап тху»
UA6193S (uk) Машина тістомісильна «інтенсив-200»
UA4397S (uk) Тренажер «верстат комбінований»
UA6769S (uk) Тренажер «машина сміта»
UA6754S (uk) Тренажер «груди машина»
UA4401S (uk) Тренажер «брусся»
UA4418S (uk) Тренажер «лавка «скотта»
UA6110S (uk) Тренажер «дельта-машина»
UA5098S (uk) Картка пластикова «star card»
FI20011904A0 (fi) Kuntolaite
UA4986S (uk) Тренажер «трицепс-машина»
UA4404S (uk) Тренажер «трицепс-машина»
UA4775S (uk) Тренажер «гомілка машина у нахилу»
UA9878S (uk) Рекламний макет «бублик»
UA7061S (uk) Гра настільна «хокей»